10.2 Benign Breast Diseases & Breast Carcinoma

Benign Breast Diseases & Breast Carcinoma

Breast pathology ranges from benign developmental aberrations (ANDI - Aberrations of Normal Development and Involution) to life-threatening invasive carcinomas. A solid understanding of clinical presentation, diagnostic algorithms, staging, and surgical techniques is vital for UPSC CMS aspirants.

---

1. Benign Breast Conditions

Fibroadenoma

• Demographics: Most common benign breast tumor in young women aged 15-30 years.
• Pathology: Benign biphasic tumor consisting of epithelial and stromal elements. Histologically exhibits pericanalicular or intracanalicular growth patterns.
• Clinical Features: Painless, firm, smooth, rubbery, well-circumscribed mass. Highly mobile within breast tissue, earning the classical sobriquet "breast mouse".
• Giant Fibroadenoma: Defined as fibroadenoma >5 cm in size or >500 grams in weight.
• Management: Reassurance and observation for small (<2 cm) lesions in young women (<25 yrs). Surgical excision indicated if >3 cm, rapidly growing, painful, or patient >35 years.

Fibrocystic Disease (Mammary Dysplasia)

• Etiology: Aberrant response of breast tissue to cyclical ovarian hormonal stimulation (estrogen excess / progesterone deficiency).
• Clinical Features: Cyclical mastalgia (worse premenstrually) and painful bilateral, diffuse, lumpy breast nodularity.
• Histology: Cysts, apocrine metaplasia, sclerosing adenosis, and ductal epithelial hyperplasia. Epithelial hyperplasia with atypia carries a 4-5x increased risk of breast cancer.

Phyllodes Tumor (Cystosarcoma Phyllodes)

• Pathology: Biphasic tumor with hypercellular stromal proliferation showing characteristic leaf-like projections under microscopy. Classified as Benign (70%), Borderline (15%), or Malignant (15%).
• Clinical Features: Fast-growing, large, bosselated breast mass in women aged 40-50 years. Overlying skin is shiny, stretched, with dilated superficial veins, but non-adherent to skin/chest wall.
• Management: Wide local excision with a 1 cm clear margin. Axillary lymph node dissection is NOT required because phyllodes tumors spread via the hematogenous route (metastasis to lungs/bones) rather than lymphatics.

Intraductal Papilloma

• Clinical Presentation: Most common cause of spontaneous bloody or serosanguinous single-duct nipple discharge.
• Location: Typically subareolar in major lactiferous ducts.
• Management: Microdochectomy (excision of single affected duct - Urban procedure) or Hadfield's operation (total duct excision).

Fat Necrosis

• Etiology: Follows direct breast trauma, prior surgery, or radiotherapy.
• Clinical Significance: Mimics breast carcinoma both clinically (hard, irregular, fixed mass with skin tethering) and radiologically. Biopsy is essential and reveals lipid-laden foam cells, multinucleated giant cells, and cholesterol clefts.

---

2. Triple Assessment & Mammography

Any patient presenting with a discrete breast lump must undergo the Triple Assessment to achieve 99.9% diagnostic accuracy:

1. Clinical Examination: History, bilateral breast inspection, palpation, and regional lymph node evaluation.
2. Diagnostic Imaging:
   • Ultrasound (USG): Modality of choice in women <35 years (dense fibroglandular parenchyma). Excellent for differentiating fluid-filled cysts from solid masses.
   • Mammography: Modality of choice in women ≥35 years. Standard views: Craniocaudal (CC) and Mediolateral Oblique (MLO). Malignant features include irregular spicated masses, architectural distortion, and pleomorphic microcalcifications clustered (>5 per cm³).
   • BI-RADS Classification: BIRADS 1 (Normal), BIRADS 2 (Benign), BIRADS 3 (Probably benign, <2% risk, follow-up in 6 mo), BIRADS 4 (Suspicious, biopsy recommended), BIRADS 5 (Highly suggestive of malignancy, >95% risk), BIRADS 6 (Known biopsy-proven malignancy).
3. Histopathological Confirmation:
   • Core Needle Biopsy (CNB): Gold Standard. Uses a 14-gauge automated tru-cut needle. Provides tissue architecture to distinguish invasive from in situ carcinoma and permits ER, PR, HER2 receptor testing.
   • FNAC: Cytological assessment only; cannot distinguish invasive ductal carcinoma from DCIS.

---

3. Histological Types & Molecular Subtypes of Breast Carcinoma

• Invasive Ductal Carcinoma - Not Otherwise Specified (IDC-NOS): Accounts for 75-80% of all breast cancers.
• Invasive Lobular Carcinoma (ILC): Accounts for 10-15%. Characterized by loss of E-cadherin expression. Frequently bilateral and multicentric. Shows an 'Indian file' pattern of single cells invading stroma.

Molecular Subtypes Table

---

4. TNM Staging & Surgical Management

TNM Clinical Staging Highlights

• T1: Tumor ≤ 2 cm in greatest dimension.
• T2: Tumor > 2 cm but ≤ 5 cm.
• T3: Tumor > 5 cm.
• T4: T4a (chest wall fixation), T4b (skin involvement: ulceration, peau d'orange [dermal lymphatic embolization], skin nodules), T4c (both T4a and T4b), T4d (Inflammatory Breast Cancer - diffuse erythema, edema covering >1/3 of breast).
• N1: Mobile ipsilateral Level I/II axillary lymph nodes.
• N2: Fixed/matted ipsilateral axillary nodes.
• N3: Ipsilateral infraclavicular (Level III), internal mammary, or supraclavicular nodes.

Surgical Operations

1. Breast Conservation Therapy (BCT):
   • Components: Wide Local Excision (WLE with 1 cm clear margin) + Sentinel Lymph Node Biopsy (SLNB) / Axillary Lymph Node Dissection (ALND) + Whole Breast Postoperative Radiotherapy.
   • Absolute Contraindications: Multicentric disease (tumors in different quadrants), widespread malignant microcalcifications, prior chest wall radiation, persistent positive surgical margins after re-excision, pregnancy in 1st/2nd trimester.
2. Modified Radical Mastectomy (MRM):
   • Auchincloss Procedure: Removes total breast tissue, nipple-areola complex, skin, pectoralis major fascia, and Level I & II axillary lymph nodes. Preserves pectoralis minor.
   • Patey Procedure: Includes division or excision of pectoralis minor to access Level III axillary nodes.

Axillary Dissection & Nerves at Risk

• Level I Nodes: Lateral to lateral border of pectoralis minor.
• Level II Nodes: Deep to pectoralis minor.
• Level III Nodes: Medial to medial border of pectoralis minor.
• Nerves to Preserve:
  1. Long Thoracic Nerve of Bell: Arises from C5, C6, C7; runs along lateral thoracic wall to supply Serratus Anterior. Injury leads to winged scapula (inability to push against a wall or abduct arm above 90°).
  2. Thoracodorsal Nerve: Supplies Latissimus Dorsi. Injury causes loss of extension, adduction, and internal rotation of the shoulder.
  3. Intercostobrachial Nerve: Sensory nerve crossing axilla; transection causes numbness over the upper medial arm.